These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

583 related articles for article (PubMed ID: 29506866)

  • 1. Direct oral anticoagulant (DOAC) versus low-molecular-weight heparin (LMWH) for treatment of cancer associated thrombosis (CAT): A systematic review and meta-analysis.
    Li A; Garcia DA; Lyman GH; Carrier M
    Thromb Res; 2019 Jan; 173():158-163. PubMed ID: 29506866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticoagulation for the long-term treatment of venous thromboembolism in people with cancer.
    Kahale LA; Hakoum MB; Tsolakian IG; Matar CF; Terrenato I; Sperati F; Barba M; Yosuico VE; Schünemann H; Akl EA
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD006650. PubMed ID: 29920657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DOAC compared to LMWH in the treatment of cancer related-venous thromboembolism: a systematic review and meta-analysis.
    Mai V; Tanguay VF; Guay CA; Bertoletti L; Magnan S; Turgeon AF; Lacasse Y; Lega JC; Provencher S
    J Thromb Thrombolysis; 2020 Oct; 50(3):661-667. PubMed ID: 32052314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct oral anticoagulants for cancer-associated venous thromboembolism: a systematic review and meta-analysis.
    Mulder FI; Bosch FTM; Young AM; Marshall A; McBane RD; Zemla TJ; Carrier M; Kamphuisen PW; Bossuyt PMM; Büller HR; Weitz JI; Middeldorp S; van Es N
    Blood; 2020 Sep; 136(12):1433-1441. PubMed ID: 32396939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct oral anticoagulant versus low-molecular-weight heparin for treatment of venous thromboembolism in cancer patients: An updated meta-analysis of randomized controlled trials.
    Haykal T; Zayed Y; Deliwala S; Kerbage J; Ponnapalli A; Malladi S; Goranta S; Samji V; Adam S
    Thromb Res; 2020 Oct; 194():57-65. PubMed ID: 32788122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct oral anticoagulant (DOAC) versus low-molecular-weight heparin (LMWH) for the treatment of cancer-associated thrombosis (which agent for which patient).
    Pernod G; Joly M; Sonnet B
    J Med Vasc; 2020 Nov; 45(6S):6S17-6S23. PubMed ID: 33276939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Editor's Choice - A Systematic Review and Meta-Analysis of the Efficacy and Safety of Anticoagulation in the Treatment of Venous Thromboembolism in Patients with Cancer.
    Kirkilesis GI; Kakkos SK; Tsolakis IA
    Eur J Vasc Endovasc Surg; 2019 May; 57(5):685-701. PubMed ID: 31097186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of direct oral anticoagulants versus low-molecular-weight heparin for thromboprophylaxis after cancer surgery: a systematic review and meta-analysis.
    Zhou H; Chen TT; Ye LL; Ma JJ; Zhang JH
    World J Surg Oncol; 2024 Feb; 22(1):69. PubMed ID: 38403630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticoagulation for the Treatment of Cancer-Associated Thrombosis: A Systematic Review and Network Meta-Analysis of Randomized Trials.
    Sobieraj DM; Baker WL; Smith E; Sasiela K; Trexler SE; Kim O; Coleman CI
    Clin Appl Thromb Hemost; 2018 Dec; 24(9_suppl):182S-187S. PubMed ID: 30244595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct Oral Anticoagulant for the Treatment of VTE in Cancer Patients: A Systematic Review and Meta-analysis.
    Dong S; Zhang Y; Li Y; Li Y; Miao Y; Zhao R; Zhai S
    Ann Pharmacother; 2021 Apr; 55(4):430-439. PubMed ID: 32938202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of direct oral anticoagulants for secondary prevention of cancer associated thrombosis: a meta-analysis of randomized controlled trials.
    Desai R; Koipallil GK; Thomas N; Mhaskar R; Visweshwar N; Laber D; Patel A; Jaglal M
    Sci Rep; 2020 Nov; 10(1):18945. PubMed ID: 33144679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct oral anticoagulants more effective than low-molecular-weight heparin for venous thrombo-embolism in cancer: an updated meta-analysis of randomized trials.
    Brunetti ND; Tricarico L; Correale M; De Gennaro L; Santoro F; Ieva R; Di Biase M
    J Thromb Thrombolysis; 2020 Aug; 50(2):305-310. PubMed ID: 31654194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Network meta-analysis of anticoagulation strategies for venous thromboembolism in patients with cancer.
    Ueyama H; Miyashita H; Takagi H; Cruz C; Burger A; Briasoulis A; Kuno T
    J Thromb Thrombolysis; 2021 Jan; 51(1):102-111. PubMed ID: 32458316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct Oral Anticoagulants for the Treatment of Acute Venous Thromboembolism Associated with Cancer: A Systematic Review and Meta-Analysis.
    Giustozzi M; Agnelli G; Del Toro-Cervera J; Klok FA; Rosovsky RP; Martin AC; Herold J; Tzoran I; Szmit S; Bertoletti L; Becattini C; Huisman MV
    Thromb Haemost; 2020 Jul; 120(7):1128-1136. PubMed ID: 32365386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticoagulant therapy for acute venous thrombo-embolism in cancer patients: A systematic review and network meta-analysis.
    Rossel A; Robert-Ebadi H; Combescure C; Grosgurin O; Stirnemann J; Addeo A; Garin N; Agoritsas T; Reny JL; Marti C
    PLoS One; 2019; 14(3):e0213940. PubMed ID: 30897142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct oral anticoagulants (DOACs) versus low-molecular-weight heparin (LMWH) for extended thromboprophylaxis following major abdominal/pelvic cancer-related surgery: a systematic review and meta-analysis.
    Zhou H; Ye LL; Zhou JT; Ma FX; Ma JJ; Zhang JH
    Surg Endosc; 2024 Mar; 38(3):1131-1138. PubMed ID: 38267639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor Xa Inhibition for the Treatment of Venous Thromboembolism Associated With Cancer: A Meta-Analysis of the Randomised Controlled Trials.
    Murphy AC; Koshy AN; Farouque O; Yeo B; Raman J; Kearney L; Yudi MB
    Heart Lung Circ; 2022 May; 31(5):716-725. PubMed ID: 34896013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct Oral Anticoagulants vs Low-Molecular-Weight Heparin and Recurrent VTE in Patients With Cancer: A Randomized Clinical Trial.
    Schrag D; Uno H; Rosovsky R; Rutherford C; Sanfilippo K; Villano JL; Drescher M; Jayaram N; Holmes C; Feldman L; Zattra O; Farrar-Muir H; Cronin C; Basch E; Weiss A; Connors JM;
    JAMA; 2023 Jun; 329(22):1924-1933. PubMed ID: 37266947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of direct oral anticoagulants versus low-molecular-weight heparin in patients with cancer: a systematic review and meta-analysis.
    Dong Y; Wang Y; Ma RL; Liu M; Gao JZ; Su WY; Yan L; Sun JJ
    J Thromb Thrombolysis; 2019 Oct; 48(3):400-412. PubMed ID: 31062143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of venous thromboembolism in patients with cancer with direct oral anticoagulants: A systematic review and meta-analysis.
    Chen H; Tao R; Zhao H; Jiang J; Yang J
    Medicine (Baltimore); 2020 Jan; 99(5):e19000. PubMed ID: 32000440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.